webinar register page

IBRI Science Frontiers: Diabetic Kidney Disease Remains a Scourge
Matt Breyer, MD, distinguished scientist in the cardiovascular metabolic group at Janssen Pharmaceutical Company, will present, "Diabetic Kidney Disease Remains a Scourge Despite SGLT2 Inhibitor Benefit."

Jul 6, 2022 09:00 AM in Indiana (East)

* Required information
Loading